The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — all time page 32

Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,535 topics · page 32 of 40

TopicParticipantsRepliesViewsActivity
Review cadence: how often is a page actually re-checked?
Asking directly, because I could not find a straight answer: Review cadence: how often is a page actually re-checked? Nominating something for promotion into the documentation commons. The topic in question…
RHPTATJSS+20 24 20k 15mo
SURMOUNT-4 and what withdrawal data does and does not tell an individual
SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 8 ( JAMA , 2022)…
NSLMAADKA 4 42k 11mo
Coming back to: Swirling versus inverting versus leaving it alone
Swirling versus inverting versus leaving it alone Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how quickly…
MMBRAMCDSB+20 24 16k 26d
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in…
SBSKGF 2 46k 11mo
Training through a dose escalation week
Training through a dose escalation week — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that almost nobody writes about. I have…
KJFYMHEST 4 42k 20mo
Follow-up: The retatrutide phase 2 obesity paper, read closely
The retatrutide phase 2 obesity paper, read closely — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
JBZOCRJATV+19 23 16k 2d
Getting a referral rather than a refusal
Getting a referral rather than a refusal — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the difference and I would…
BPTMIPNIT+8 12 32k 2mo
Tirzepatide storage and stability: what is published versus what is assumed
On the subject in the title: Tirzepatide storage and stability: what is published versus what is assumed Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read…
APPOELIGR+17 21 17k 12d
Request: a diff view for wiki revisions
Request: a diff view for wiki revisions — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
MHJCFSMT+26 30 3.1k 19mo
Whether an aggregate is worth publishing at all: a disputed topic
On the subject in the title: Whether an aggregate is worth publishing at all: a disputed topic Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
PEGLIGHNMD+20 24 18k 13mo
Conditions that change the calculus rather than forbidding it
Conditions that change the calculus rather than forbidding it Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
ALAABFPMRL+28 32 6.1k 1d
Follow-up: Reconciling a label claim with a content assay
Reconciling a label claim with a content assay Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it anywhere.…
RRBVTITNAE+26 30 6.5k 14d
Second pass at: Historical amylin analogues and what happened to them
Second pass at: Historical amylin analogues and what happened to them — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim…
ALCIPFBSV+15 19 22k 18mo
Composite endpoints and the component doing the work
Composite endpoints and the component doing the work Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I do…
RVIDSSVKFP+3 7 33k 13h
Retatrutide's phase 2 heart-rate signal and how to think about it
On the subject in the title: Retatrutide's phase 2 heart-rate signal and how to think about it Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a claim…
MVBERMBJER+19 23 20k 7mo
A calculator that gives a right answer to the wrong question
Posting this under the heading it deserves: A calculator that gives a right answer to the wrong question Everything below is what sits behind that. I would like to understand what this number means before I…
FABATPFVFF+32 36 1.9k 17h
Coming back to: Lurking for two months before posting: was that the right call?
The question in the title: Lurking for two months before posting: was that the right call? I will give what I have already checked below so nobody repeats it. I want to check my reasoning rather than get a…
BOJVALGVTT+28 32 3.3k 11mo
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. I would like to understand what this number means…
BRIJVPYR+7 11 31k 17mo
Non-inferiority margins: how they are chosen and how they are abused — a second dataset
Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with…
FTJIRHAAP+32 37 574 5mo
Hello from a laboratory that does not do peptides — does this still hold?
Asking directly, because I could not find a straight answer: Hello from a laboratory that does not do peptides — does this still hold? Lower-stakes topic, but the sourcing rule still applies if anyone makes a…
JPJCOVOI+1 5 35k 19mo
Pages past their review date, listed
Pages past their review date, listed Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The topic in question…
CLONKSHFF+26 30 6.4k 10mo
Follow-up: I have no scientific background — can I still follow the analytics categories?
Asking directly, because I could not find a straight answer: I have no scientific background — can I still follow the analytics categories? Question in the title. Context below, and I have tried to include…
VNMVPPNSPR+15 19 15k 1mo
Currency conversion and the cost you did not see
Currency conversion and the cost you did not see — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
ELSGLE 2 44k 2mo
About the Resistance training category
Programming while losing weight quickly, realistic expectations, and recovery. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLKAICRJM 4 40k 17d
What steady state means for the decision to escalate
What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. Reporting something rather than asking about it, in case the…
LWPADMHKM+31 35 2k 1d
Follow-up: Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a…
CLBKSS 2 41k 14mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept Reporting something rather than asking about it, in case the pattern…
BWSANTIRSS+7 11 26k 9mo
Revisiting: Body image changing more slowly than the body
Posting this under the heading it deserves: Revisiting: Body image changing more slowly than the body Everything below is what sits behind that. General question, not a request for advice about my own care —…
JNCNSFOCPB+5 9 28k 8h
An orphaned page with no inbound links — the long version
Posting this under the heading it deserves: An orphaned page with no inbound links — the long version Everything below is what sits behind that. Process question about how this site works. I have read the…
KGTNEKIA+14 18 21k 10mo
Revisiting: A field-by-field walk through a certificate of analysis
Revisiting: A field-by-field walk through a certificate of analysis Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I…
HFRJPNEAPK+37 41 656 3mo